SHYAM SUNDER SHARMA

Employment

• National Institute of Pharmaceutical Education and Research Professor
  2009 - Present

Education

• All India Institute of Medical Sciences PhD
  1993 - 1997

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• Transient Receptor Potential Channels in Modulating Synaptic Plasticity and Cognitive Function: Potential Role of Pharmacological Agents
  Basic & Clinical Pharmacology & Toxicology 2026 DOI: 10.1111/bcpt.70248
  +Save
• Cardioprotective Potential of ApoE-Derived Peptide (ApoEFrag) in Myocardial Infarction in Rats: A Mechanistic Study
  ACS Pharmacology & Translational Science 2025 DOI: 10.1021/acsptsci.4c00759
  +Save
• Decoding the Nectin Interactome: Implications for Brain Development, Plasticity, and Neurological Disorders
  ACS Chemical Neuroscience 2025 DOI: 10.1021/acschemneuro.5c00069
  +Save
• HC070, a Transient Receptor Potential Canonical 5 (TRPC5) Channels Inhibitor Ameliorated α‐synuclein Preformed Fibrils‐Induced Parkinson's Disease: A Neurobehavioural and Mechanistic Study
  Journal of Biochemical and Molecular Toxicology 2025 DOI: 10.1002/jbt.70207
  +Save
• RNA Interference Unleashed: Current Perspective of Small Interfering RNA (siRNA) Therapeutics in the Treatment of Neuropathic Pain
  ACS Pharmacology & Translational Science 2024 DOI: 10.1021/acsptsci.4c00329
  +Save
• Pharmacological agents targeting transient receptor potential (TRP) channels in neuropathic pain: Preclinical and clinical status
  European Journal of Pharmacology 2024 DOI: 10.1016/j.ejphar.2024.176845
  +Save
• Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions
  Basic & Clinical Pharmacology & Toxicology 2024 DOI: 10.1111/bcpt.14073
  +Save
• Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model
  Neurochemistry International 2024 DOI: 10.1016/j.neuint.2024.105691
  +Save
• Transient Receptor Potential Canonical 5 (TRPC5) Channels Activator, BTD [N-{3-(adamantan-2-yloxy)-propyl}-3-(6-methyl-1,1-dioxo-2H-1λ6,2,4- benzothiadiazin-3-yl)-propanamide)] Ameliorates Diabetic Cardiac Autonomic Neuropathy in Rats
  Current Neurovascular Research 2023 DOI: 10.2174/1567202620666230403134627
  +Save
• BTD: A TRPC5 activator ameliorates mechanical allodynia in diabetic peripheral neuropathic rats by modulating TRPC5-CAMKII-ERK pathway
  Neurochemistry International 2023 DOI: 10.1016/j.neuint.2023.105609
  +Save